The clustering of KRAS and ADAMTS19, genes known to be involved in endometriosis-associated ovarian cancer, also provides a molecular foundation for potential malignant transformation, emphasizing the disease’s multifaceted impact [33,34]. This evidence concerns the gene KRAS and endometriosis.